SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-15-001266
Filing Date
2015-02-12
Accepted
2015-02-12 16:39:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 n210150sc13g.htm SC 13G 62239
  Complete submission text file 0001214659-15-001266.txt   63664
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Subject) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88653 | Film No.: 15606893
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411
Business Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411 81-3-3244-3231
Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

IRS No.: 132971791
Type: SC 13G